7 news items
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
MBOT
20 Jun 24
lingering uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
MBOT
17 Jun 24
hostilities between Israel and the Palestinians and other neighboring countries, any lingering uncertainty resulting from the COVID-19 pandemic, need
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
MBOT
4 Jun 24
and other neighboring countries, any lingering uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
MBOT
3 Jun 24
and the Palestinians and other neighboring countries, any lingering uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
MBOT
3 Jun 24
and the Palestinians and other neighboring countries, any lingering uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future
l73rdhy1 4rsmq2tozvg7twdhv9pzj7u1d2u
MBOT
29 Apr 24
resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information
2c2 xogtzp
MBOT
15 Apr 24
pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical
- Prev
- 1
- Next